• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Medicinal cannabis concerns include psychosis and child poisonings. We’re not the only ones worried

The Conversation
The Conversation

Medicinal cannabis was legalised in Australia in 2016. But use really took off in 2021, when the TGA changed how people could access the unapproved products. Use in young men has been increasing the fastest. Generally, about one-third of use is for anxiety. This is despite TGA guidance stating medicinal cannabis containing THC (tetrahydrocannabinol) is generally not appropriate for patients who “have a previous psychotic or concurrent active mood or anxiety disorder”.

Posted in: News on 09/16/2025 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2025 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice